Drugs for Hydrocephalus, Congenital, 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 17)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Indomethacin |
Approved, Investigational |
Phase 3 |
|
53-86-1 |
3715 |
Synonyms:
{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetate
{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid
1-(P-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetate
1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid
1-(P-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid
1z9h
37242-43-6
503560-73-4
53-86-1
74252-25-8 (hydrochloride salt, tri-hydrate)
7681-54-1 (hydrochloride salt)
91853-74-6
AB00052022
AC1L1GJQ
AC-532
Aconip
Aconip (TN)
AKOS000592893
Amuno
Apo-Indomethacin
Argun
Arthrexin
Artracin
Artrinovo
Artrivia
BIDD:GT0132
BIM-0050670.0001
Bio-0704
Bio2_000405
Bio2_000885
Bonidin
Bonidon
Bonidon Gel
BPBio1_000160
BRD-K57222227-001-06-1
BRN 0497341
BSPBio_000144
BSPBio_001149
BSPBio_002176
C01926
CAS-53-86-1
Catlep
CCRIS 3502
CHEBI:49662
CHEMBL6
Chibro-amuno
Chibro-Amuno
Chrono-indicid
Chrono-Indicid
Chrono-indocid
Chrono-Indocid
CID3715
Confortid
CPD-10545
D00141
DB00328
DESMETHYL INDOMETHACIN
DivK1c_000271
Dolcidium
Dolcidium Pl
Dolcidium PL
Dolovin
Durametacin
EINECS 200-186-5
Elmetacin
EU-0100692
Flexin continus
Flexin Continus
Hicin
HMS1362I11
HMS1568H06
HMS1792I11
HMS1920F21
HMS1990I11
HMS2089N19
HMS2091N09
HMS500N13
HSDB 3101
Hydrochloride, indomethacin
I 7378
I0655
I7378_SIGMA
I8280_SIGMA
IDI1_000271
IDI1_002160
Idomethine
Imbrilon
IMN
IN1454
Inacid
Indacin
Indaflex
Indameth
Indmethacine
Indocid
Indocid (pharmaceutical)
Indocid Pda
Indocid Sr
Indocin
Indocin (TN)
Indocin I.V
Indocin I.V.
Indocin Sr
Indolar Sr
Indolar SR
Indo-Lemmon
Indomecol
Indomed
Indomee
Indomet 140
indometacin
Indometacin
Indometacin (JP15/INN)
Indometacina
Indometacina [INN-Spanish]
Indometacine
Indometacine [INN-French]
Indometacinum
Indometacinum [INN-Latin]
Indometacyna
|
Indometacyna [Polish]
indomethacin
Indomethacin
Indomethacin & MAP-30
Indomethacin (USP)
Indomethacin [USAN:BAN]
Indomethacin hydrochloride
Indomethacin, Indochron E-R, Indocin-SR, Indocid, Indocin, Indomethacin
Indomethacine
Indomethacinum
Indomethancin
Indomethazine
Indomethegan
Indomethine
Indometicina
Indometicina [Spanish]
Indomo
Indomod
Indo-phlogont
Indo-Phlogont
Indoptic
Indoptol
Indo-rectolmin
Indo-Rectolmin
Indorektal
Indo-Spray
Indo-tablinen
Indo-Tablinen
Indoxen
Inflazon
Infrocin
Inteban sp
Inteban Sp
KBio1_000271
KBio2_000489
KBio2_001399
KBio2_003057
KBio2_003967
KBio2_005625
KBio2_006535
KBio3_000897
KBio3_000898
KBio3_001396
KBioGR_000395
KBioGR_000489
KBioSS_000489
KBioSS_001399
L000959
Lausit
Liometacen
Lopac0_000692
Lopac-I-7378
LS-187
LS-82147
Metacen
Metartril
Methazine
Metindol
Mezolin
Miametan
Mikametan
MLS000069402
MLS000758212
MLS001074194
Mobilan
MolMap_000032
MolPort-000-917-894
NCGC00015562-01
NCGC00015562-02
NCGC00015562-03
NCGC00015562-08
NCGC00015562-19
NCGC00024135-02
NCGC00024135-04
NCGC00024135-05
NCGC00024135-06
NCGC00024135-07
NCGC00024135-08
NCGC00024135-09
NCGC00024135-11
nchembio.147-comp11
NCI60_041708
NCI-C56144
NINDS_000271
Novomethacin
Novo-Methacin
Nu-Indo
Oprea1_686105
Osmosin
Prestwick_597
Prestwick0_000272
Prestwick1_000272
Prestwick2_000272
Prestwick3_000272
Reumacide
Rhemacin La
Rhemacin LA
Rheumacin La
Rheumacin LA
S00108
S1723_Selleck
Sadoreum
SMR000058195
SMR000449290
SPBio_000979
SPBio_002363
Spectrum_000919
SPECTRUM1500350
Spectrum2_000970
Spectrum3_000468
Spectrum4_000018
Spectrum5_000868
Tannex
Tocris-1708
UNII-XXE1CET956
UPCMLD-DP023
UPCMLD-DP023:001
USAN
Vonum
|
|
2 |
|
Analgesics, Non-Narcotic |
|
Phase 3 |
|
|
|
3 |
|
Anti-Inflammatory Agents |
|
Phase 3 |
|
|
|
4 |
|
Analgesics |
|
Phase 3 |
|
|
|
5 |
|
Tocolytic Agents |
|
Phase 3 |
|
|
|
6 |
|
Cyclooxygenase Inhibitors |
|
Phase 3 |
|
|
|
7 |
|
Antirheumatic Agents |
|
Phase 3 |
|
|
|
8 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 3 |
|
|
|
9 |
|
Caffeine |
Approved |
Phase 2 |
|
58-08-2 |
2519 |
Synonyms:
07E4FB58-FD79-4175-8E3D-05BF96954522
1,3,7-trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-trimethylpurine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-trimethylxanthine
1,3,7-Trimethylxanthine
1-3-7-TRIMETHYLXANTHINE
137X
1gfz
1l5q
1l7x
1-methyltheobromine
1-Methyltheobromine
1-Methyl-theobromine
27602_FLUKA
2a3b
3,7-dihydro-1,3,7-Trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-dihydro-1,3,7-trimethyl-1H-purine
3,7-dihydro-1,3,7-Trimethyl-1H-purine-2,6-dione
5-26-13-00558 (Beilstein)
58-08-2
71701-02-5
75035_FLUKA
7-Methyl theophylline
7-methyltheophylline
7-Methyltheophylline
95789-13-2
A.S.A. and Codeine Compound
AC-12774
AC1L1DV2
AC1Q3Z23
ACon1_000085
AI3-20154
AKOS000121334
Alert-pep
Alert-Pep
Anacin Maximum Strength
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anhydrous caffeine (TN)
Anoquan
Berlin-chemie brand OF caffeine
Berlin-Chemie Brand of Caffeine
BIDD:ER0554
BIDD:GT0632
BIDD:PXR0172
BIM-0050216.0001
Bio-0579
Bio1_000473
Bio1_000962
Bio1_001451
bmse000206
BRD-K02404261-001-02-7
BRD-K02404261-001-03-5
Bristol-myers squibb brand OF caffeine
Bristol-Myers Squibb Brand of Caffeine
BRN 0017705
BSPBio_001921
C 0750
C07481
C0750_SIAL
C1778_SIAL
C2042
C6035_FLUKA
C6035_SIGMA
C7731_SIAL
C8960_SIAL
Cafamil
Cafcit
Cafecon
Cafeina
Cafeína
cafeine
Cafeine
Caféine
Cafergot
Caffedrine
Caffedrine Caplets
Caffein
Caffeina
Caffeina [Italian]
caffeine
Caffeine (natural)
Caffeine (USP)
Caffeine [BAN:JAN]
Caffeine Pure
Caffeine solution
Caffeine, anhydrous
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, synthetic
Caffeine, Synthetic
Caffeinum
caffenium
Caffine
Cafipel
CCRIS 1314
CFF
CHEBI:27732
CHEMBL113
CID2519
Coffein
Coffein [German]
Coffeine
Coffeinum
Coffeinum N
Coffeinum purrum
Coffeinum Purrum
component of Cafergot
Compound 65
CU-01000012617-3
D002110
D00528
Darvon Compound
Darvon Compound-65
Dasin
DB00201
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
DHC Plus
DHCplus
Diurex
DivK1c_000730
Durvitan
EINECS 200-362-1
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
EU-0100228
FEMA No. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline brand OF caffeine
GlaxoSmithKline Brand of Caffeine
Guaranine
HMS1920I09
HMS2091O11
HMS502E12
HSDB 36
Hycomine
|
Hycomine Compound
I14-4386
IDI1_000730
Invagesic
Invagesic Forte
KBio1_000730
KBio2_001781
KBio2_004349
KBio2_006917
KBio3_001141
KBioGR_002325
KBioSS_001781
Keep Alert
Kofein
Kofein [Czech]
Koffein
Koffein [German]
L000155
Lanorinal
Lopac0_000228
Lopac-C-0750
LS-237
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
MEGxp0_001350
Merck dura brand OF caffeine
Merck dura Brand of Caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Midol Maximum Strength
Migergot
Miudol
MLS001055341
MLS001056714
MLS001066409
MolMap_000054
MolPort-000-730-850
Monohydrate caffeine
Monomethyl derivative of Theophylline
Monomethyl Derivative of Theophylline
Natural Caffeinum
NCGC00015208-01
NCGC00015208-02
NCGC00015208-04
NCGC00015208-14
NCGC00090699-01
NCGC00090699-02
NCGC00090699-03
NCGC00090699-04
NCGC00090699-05
NCGC00090699-06
NCGC00090699-07
NCGC00090699-08
NCGC00090699-09
NCGC00168808-01
NCGC00168808-02
nchembio.243-comp7
nchembio.63-comp5
nchembio774-comp2
NCI-C02733
NCIOpen2_008255
NINDS_000730
Nix Nap
no Doz
No Doz
Nodaca
No-Doz
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
NSC 5036
NSC5036
Organex
Orphengesic
Orphengesic Forte
P-A-C Analgesic Tablets
Passauer brand OF caffeine
Passauer Brand of Caffeine
PDSP1_001016
PDSP1_001235
PDSP2_001000
PDSP2_001219
Pep-Back
Percoffedrinol N
Percutafeine
Percutaféine
Phensal
Pierre fabre brand OF caffeine
Pierre Fabre Brand of Caffeine
Probes1_000150
Probes2_000128
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick Pep
Quick-pep
Quick-Pep
Refresh'n
Republic drug brand OF caffeine
Republic Drug Brand of Caffeine
SDCCGMLS-0064595.P001
SDCCGMLS-0064595.P002
Seid brand OF caffeine
Seid Brand of Caffeine
SK 65 Compound
SK-65 Compound
SMR000326667
SPBio_001222
Spectrum_001301
SPECTRUM1500155
Spectrum2_001261
Spectrum3_000321
Spectrum4_001782
Spectrum5_000423
Stim
STK177283
Synalgos-Dc
teina
Teina
Teína
Thein
Theine
Theobromine Me
Theobromine ME
Theophylline Me
Theophylline ME
Theophylline, 7-methyl
Thompson brand 1 OF caffeine
Thompson Brand 1 of Caffeine
Thompson brand 2 OF caffeine
Thompson Brand 2 of Caffeine
Tirend
TNP00310
Triad
Tri-Aqua
Ultra Pep-Back
UNII-3G6A5W338E
Vivarin
W222402_ALDRICH
Wake-Up
Wigraine
WLN: T56 BN DN FNVNVJ B1 F1 H1
Xanthine, 1,3,7-trimethyl
ZINC00001084
|
|
10 |
|
Phosphodiesterase Inhibitors |
|
Phase 2 |
|
|
|
11 |
|
Central Nervous System Stimulants |
|
Phase 2 |
|
|
|
12 |
|
Pharmaceutical Solutions |
|
Phase 2 |
|
|
|
13 |
|
Tin Fluorides |
|
Phase 2 |
|
|
|
14 |
|
Neurotransmitter Agents |
|
Phase 2 |
|
|
|
15 |
|
Propofol |
Approved, Investigational, Vet_approved |
|
|
2078-54-8 |
4943 |
Synonyms:
2, 6-Diisopropylphenol
2,6 Diisopropylphenol
2,6-bis(1-methylethyl)phenol
2,6-bis(1-methylethyl)-phenol
2,6-Bis(1-methylethyl)phenol
2,6-Bis(Isopropyl)-phenol
2,6-di(propan-2-yl)phenol
2,6-Diisopropyl phenol
2,6-Diisopropylphenol
2,6-DIISOPROPYLPHENOL
2078-54-8
28449-97-0
4-06-00-03435 (Beilstein Handbook Reference)
50356-15-5
AB00513968
Abbott brand OF propofol
Abbott Brand of Propofol
AC1L1J9Y
AC1Q1OUI
AC-2038
AI3-26295
Alpha Brand of Propofol
Alpha Brand OF propofol
AM-149
Ampofol
Aquafol
Astra brand OF propofol
Astra Brand of Propofol
AstraZeneca brand OF propofol
AstraZeneca Brand of Propofol
BIDD:GT0436
Biomol-NT_000248
BPBio1_000950
BPBio1_000969
Braun brand OF propofol
Braun Brand of Propofol
BRD-K82255054-001-03-5
BRN 1866484
BSPBio_000862
C07523
C12H18O
CAS-2078-54-8
CCRIS 9000
CHEBI:44915
CHEMBL526
CID4943
CPD000059151
CPD-11437
Curamed brand OF propofol
Curamed Brand of Propofol
D00549
D015742
D0617
D126608
D126608_ALDRICH
DB00818
DDS-04F
Diisopropylphenol
Dipravan
Diprivan
Diprivan (TN)
Diprivan Injectable emulsion
Disoprivan
Disoprofol
EINECS 218-206-6
EU-0100437
Fresenius brand OF propofol
Fresenius Brand of Propofol
Fresenius kabi brand OF propofol
Fresenius Kabi Brand of Propofol
Fresofol
ghl.PD_Mitscher_leg0.558
HMS1570L04
HMS2089O21
HMS2094E17
HSDB 7123
|
ICI 35,868
ICI 35868
ICI35,868
ICI-35,868
ICI35868
ICI-35868
InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H
Ivofol
Jsp004266
Juste brand OF propofol
Juste Brand of Propofol
Lopac0_000437
Lopac-D126608
LS-996
MLS001066348
MLS001335999
MLS002454360
MolPort-001-794-517
NCGC00015389-01
NCGC00015389-02
NCGC00015389-04
NCGC00015389-09
NCGC00091538-01
NCGC00091538-02
NCGC00091538-03
NCGC00091538-04
NCGC00091538-05
NCGC00091538-06
nchembio.552-comp7
NSC 5105
NSC5105
Parnell brand OF propofol
Parnell Brand of Propofol
PFL
Pisa brand OF propofol
Pisa Brand of Propofol
Prestwick0_000931
Prestwick1_000931
Prestwick2_000931
Prestwick3_000931
propofol
Propofol
Propofol (JAN/USAN/INN)
Propofol [USAN:INN:BAN]
Propofol abbott
Propofol Abbott
Propofol fresenius
Propofol Fresenius
Propofol IDD-D
Propofol MCT
Propofol rovi
Propofol Rovi
Propofol(2,6-Diisopropylphenol)
Propofol-lipuro
Propofol-Lipuro
Propofolum
Propofolum [Latin]
Rapinovet
Recofol
Rovi brand OF propofol
Rovi Brand of Propofol
S01-0189
SAM002264610
Schering brand OF propofol
Schering Brand of Propofol
SMR000059151
SPBio_003031
SPECTRUM1505022
ST50405911
UNII-YI7VU623SF
W505102_ALDRICH
ZD-0859
Zeneca brand OF propofol
Zeneca Brand of Propofol
ZINC00968303
|
|
16 |
|
Anesthetics |
|
|
|
|
|
17 |
|
Leucine |
Investigational, Nutraceutical |
|
|
61-90-5 |
6106 |
Synonyms:
(2S)-2-amino-4-Methylpentanoate
(2S)-2-amino-4-Methylpentanoic acid
(2S)-2-Amino-4-methylpentanoic acid
(2S)-a-2-amino-4-Methylvalerate
(2S)-a-2-amino-4-Methylvaleric acid
(2S)-a-Leucine
(2S)-alpha-2-amino-4-Methylvalerate
(2S)-alpha-2-amino-4-Methylvaleric acid
(2S)-alpha-2-Amino-4-methylvaleric acid
(2S)-alpha-Leucine
(2S)-α-2-amino-4-methylvalerate
(2S)-α-2-amino-4-methylvaleric acid
(2S)-α-leucine
(S)-(+)-Leucine
(S)-2-amino-4-Methylpentanoate
(S)-2-amino-4-Methylpentanoic acid
(S)-2-amino-4-Methylvalerate
(S)-2-amino-4-Methylvaleric acid
(S)-Leucine
|
2-amino-4-Methylvalerate
2-amino-4-Methylvaleric acid
2-Amino-4-methylvaleric acid
4-Methyl-L-norvaline
L
L-(+)-Leucine
L-a-Aminoisocaproate
L-a-Aminoisocaproic acid
L-alpha-Aminoisocaproate
L-alpha-Aminoisocaproic acid
Leu
Leucine
LEUCINE
Leucine, L isomer
Leucine, L-isomer
L-Isomer leucine
L-Leucin
L-Leucine
L-Leuzin
|
|
Interventional clinical trials:
(show all 22)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Randomized Controlled Trial of Two Hemoglobin Thresholds for Transfusion in Newborns <1000g Birth Weight |
Completed |
NCT00182390 |
Phase 3 |
|
2 |
Quantitative Characterization of Safe Irrigation for Ventricular Shunt Catheters |
Completed |
NCT02651337 |
Phase 3 |
|
3 |
Randomized Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial |
Completed |
NCT00033917 |
Phase 3 |
indomethacin;placebo |
4 |
Intermittent Hypoxia and Caffeine in Infants Born Preterm (ICAF) |
Recruiting |
NCT03321734 |
Phase 2 |
Caffeine;Placebos |
5 |
Prospective Follow-up of a Multicentric Cohort of Children With Prenatal Discovery of Mild Isolated Cerebral Ventriculomegaly. Evaluation at 2 and 5 Years. |
Unknown status |
NCT00421772 |
|
|
6 |
Use of Targeted Quantitative Proteomics and Metabolic Labelling With Stable Isotopes for the Diagnosis and the Investigation of Neurological Disorders and in Particular Alzheimer Disease |
Unknown status |
NCT02263235 |
|
|
7 |
Electrophysiologic Indicators of Gating and Timing Abnormalities in Autism |
Unknown status |
NCT00319722 |
|
|
8 |
Bispectral Index Monitoring of Propofol Anesthesia in Patients With Hydrocephalus. A Prospective Observational Study |
Completed |
NCT02575105 |
|
|
9 |
MRI of Ventriculomegaly: Morphology and Outcome |
Completed |
NCT00870675 |
|
|
10 |
An Audit of the Posterior Fossa Characterization in Open Spina Bifida Based on Tertiary Center Experience |
Completed |
NCT03544970 |
|
|
11 |
Endovascular Management of Pediatric Intracranial Arteriovenous Shunts |
Completed |
NCT03950258 |
|
|
12 |
Fetal Spina Bifida -Prenatal Course and Outcome in 103 Cases A Single Center Experience. |
Completed |
NCT01100697 |
|
|
13 |
MRI for Non-invasive Evaluation of Brain Stress |
Completed |
NCT01898650 |
|
|
14 |
Alterations in Cerebral Perfusion, Oxygenation, Electrical Activity, and Markers of Cerebral Damage Associated With Cerebro-spinal Fluid Reservior Aspiration in Neonates With Post Hemorrhagic Hydrocephalus |
Completed |
NCT00747682 |
|
|
15 |
Longterm Outcome of Children With Neonatal Intra-Ventricular or Intra-Cranial Hemorrhage (IVH, ICH) |
Recruiting |
NCT03019692 |
|
|
16 |
Study of Fetoscopic Repair of Myelomeningocele in Fetuses With Isolated Spina Bifida |
Recruiting |
NCT03090633 |
|
|
17 |
Advanced MR Imaging of Perinatal Brain Injury: Correlation With Neurocognitive Outcome |
Recruiting |
NCT02008045 |
|
|
18 |
Qualitative In-depth Interviews With Women and Their Partners Concerning the Acceptability of Fetal Surgery |
Recruiting |
NCT03788122 |
|
|
19 |
Prenatal Surgical Repair of Fetal Myelomeningocele |
Active, not recruiting |
NCT01983345 |
|
|
20 |
Biomarker for Hurler Disease - An International, Multicenter, Epidemiological Protocol |
Active, not recruiting |
NCT02298712 |
|
|
21 |
Isolated Mild Fetal Ventriculomegaly and Neurodevelopmental Outcome |
Terminated |
NCT00256906 |
|
|
22 |
Fetal Brain Asymmetry: in Utero and Early Neonatal Follow up |
Terminated |
NCT01707875 |
|
|
|